Skip to content

Short dental implants in the posterior region of the maxilla

Short dental implants in the posterior region of the maxilla - Short dental implants in the posterior region of the maxilla

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38862
Enrollment
36
Registered
2013-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verloren gaan van gebitselementen missing teeth

Interventions

Maxilla: Patients allocated to the control group will be treated with a bone augmentation and an 11-mm Astra implant
patients allocated to test group will be treated with a 6-mm Astra implant.

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The patient is 18 years or older - The missing or lost tooth is a premolar or molar in the maxilla - Sufficient healthy and vital bone to insert a dental implant with a length of 6 mm and a width of 4 mm - Insufficient bone height to insert an implant with a regular length - The implant site must be free from infection - Adequate oral hygiene - Sufficient occlusal dimensions for an anatomical restoration - The patient is capable of understanding and giving informed consent - Written informed consent

Exclusion criteria

Exclusion criteria: - Medical and general contraindications for the medical procedures - Presence of an active and uncontrolled periodontal disease - Bruxism - Site of implant placement is an extraction wound younger than 3 months - Smoking - A history of local radiotherapy to the neck and head region

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: Changes in marginal peri-implant bone loss.

Secondary

MeasureTime frame
Secudairy parameters/endpoints: Clinical performance and patient satisfaction.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)